专题：Adenosine and Purinergic Signaling

This cluster of papers focuses on the molecular physiology and pharmacology of purinergic signalling, including the role of adenosine receptors, P2X receptors, and nucleotide signalling in immune suppression, inflammation, neuroprotection, and the tumor microenvironment. It explores the potential therapeutic targets related to purinergic signalling.
最新文献
Fluorine‐18‐Labeled Nucleotide Analogs Targeting Ecto‐5'‐Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors

article Full Text OpenAlex

Design strategies and recent advances in activatable small molecule therapeutics

article Full Text OpenAlex

The P2X7 receptor/NLRP3 inflammasome signaling axis in sepsis: molecular mechanisms, organ-specific pathophysiology, and emerging therapeutic strategies

article Full Text OpenAlex

The potential role of adenosinergic pathway and methylxanthines in Parkinson’s disease: Blowing in the wind or not

article Full Text OpenAlex

Simultaneous Detection and Quantification of Adenine Nucleotides in Mammalian Cultured Cells by HPLC

article Full Text OpenAlex

Development and biomedical imaging applications of small-molecule fluorescent probes targeting epilepsy biomarkers

article Full Text OpenAlex

Neuroinflammatory control of metabolism in huntington’s disease: central role of P2 × 7 receptor mediated redox lipid/epigenetic crosstalk

article Full Text OpenAlex

Chronic caffeine consumption prevents obesity-induced cognitive and memory impairments by reducing neuroinflammation and enhancing neuronal activity in the hippocampus

article Full Text OpenAlex

Using dried blood spots to estimate Toxoplasma gondii seroprevalence in pregnant women in Catalonia, Spain, and to serologically diagnose congenital toxoplasmosis

article Full Text OpenAlex

Dual Action of Dipyridamole in Experimental Rheumatoid Arthritis: Suppression of Joint Inflammation and Upregulation of Muscle Anabolism via Adenosine and AMPK Pathways

article Full Text OpenAlex

近5年高被引文献
Nucleotide metabolism: a pan-cancer metabolic dependency

review Full Text OpenAlex 423 FWCI64.9124

Targeting inflammation to treat diabetic kidney disease: the road to 2030

review Full Text OpenAlex 334 FWCI43.3907

CD39/CD73/A2AR pathway and cancer immunotherapy

review Full Text OpenAlex 325 FWCI79.1785

Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials

review Full Text OpenAlex 323 FWCI27.1275

Parkinson’s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes

article Full Text OpenAlex 238 FWCI31.5365

Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation

article Full Text OpenAlex 237 FWCI33.6696

Biomarker of Neuroinflammation in Parkinson’s Disease

review Full Text OpenAlex 232 FWCI25.636

ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D

article Full Text OpenAlex 210 FWCI45.4947

Adenosine and Adenine Nucleotides As Regulators of Cellular Function

book Full Text OpenAlex 199 FWCI3.5385

Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson’s disease

article Full Text OpenAlex 199 FWCI14.482